Johnson & Johnson (NYSE:JNJ) Q4 2025 Earnings Call Transcript January 21, 2026 Johnson & Johnson reports earnings inline with ...
MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...
MITOLINE Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases - A Market Projected to Exceed $120 billion by 2030 Neve ...
Animal survival depends on effective attack and defense strategies, yet how these behaviors arise remains unclear. Addressing ...
Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look at AMGN stock prospects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback